BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Khandelwal A, Seam RK, Gupta M, Rana MK, Prakash H, Vasquez KM, Jain A. Circulating microRNA-590-5p functions as a liquid biopsy marker in non-small cell lung cancer. Cancer Sci 2020;111:826-39. [PMID: 31520555 DOI: 10.1111/cas.14199] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
Number Citing Articles
1 Lupini L, Roncarati R, Belluomini L, Lancia F, Bassi C, D’abundo L, Michilli A, Guerriero P, Fasano A, Tiberi E, Salamone A, Cosi DM, Saccenti E, Tagliatti V, Maestri I, Sabbioni S, Volinia S, Gafà R, Lanza G, Frassoldati A, Negrini M. Monitoring Somatic Genetic Alterations in Circulating Cell-Free DNA/RNA of Patients with “Oncogene-Addicted” Advanced Lung Adenocarcinoma: A Real-World Clinical Study. IJMS 2022;23:8546. [DOI: 10.3390/ijms23158546] [Reference Citation Analysis]
2 Chen P, Li X, Yu X, Yang M. Ginsenoside Rg1 Suppresses Non-Small-Cell Lung Cancer via MicroRNA-126-PI3K-AKT-mTOR Pathway. Evid Based Complement Alternat Med 2022;2022:1244836. [PMID: 35815288 DOI: 10.1155/2022/1244836] [Reference Citation Analysis]
3 Tuli HS, Sak K, Garg VK, Kumar A, Adhikary S, Kaur G, Parashar NC, Parashar G, Mukherjee T, Sharma U, Jain A, Mohapatra RK, Dhama K, Kumar M, Singh T. Ampelopsin targets in cellular processes of cancer: recent trends and advances. Toxicology Reports 2022. [DOI: 10.1016/j.toxrep.2022.07.013] [Reference Citation Analysis]
4 Xu L, Ji C, Miao X, Ge J, Li F, Xu C. Combination of circulating miR-125a-5p, miR-223-3p and D-dimer as a novel biomarker for Deep Vein Thrombosis. Am J Med Sci 2022:S0002-9629(22)00226-9. [PMID: 35588895 DOI: 10.1016/j.amjms.2022.04.033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Ren H, Shao Y, Ma X, An L, Liu Y, Wang Q. Interaction of circulating TGFβ regulatory miRNAs in different severity of diabetic kidney disease. Arch Physiol Biochem 2022;:1-15. [PMID: 35147479 DOI: 10.1080/13813455.2022.2034884] [Reference Citation Analysis]
6 Liu C, Xiang X, Han S, Lim HY, Li L, Zhang X, Ma Z, Yang L, Guo S, Soo R, Ren B, Wang L, Goh BC. Blood-based liquid biopsy: Insights into early detection and clinical management of lung cancer. Cancer Lett 2022;524:91-102. [PMID: 34656690 DOI: 10.1016/j.canlet.2021.10.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 5.0] [Reference Citation Analysis]
7 Kumar S, Saikia J, Sharawat SK, Malik PS, Kumar S, Mohan A. Analysis of miR-375-3p, miR-197-3p, and miR-15a-5p Expression and Their Clinical Relevance as Biomarkers in Lung Cancer. Technol Cancer Res Treat 2022;21:15330338221080981. [PMID: 35230198 DOI: 10.1177/15330338221080981] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Yi M, Liao Z, Deng L, Xu L, Tan Y, Liu K, Chen Z, Zhang Y. High diagnostic value of miRNAs for NSCLC: quantitative analysis for both single and combined miRNAs in lung cancer. Ann Med 2021;53:2178-93. [PMID: 34913774 DOI: 10.1080/07853890.2021.2000634] [Reference Citation Analysis]
9 Wei J, Meng G, Wu J, Wang Y, Zhang Q, Dong T, Bao J, Wang C, Zhang J. MicroRNA-326 impairs chemotherapy resistance in non small cell lung cancer by suppressing histone deacetylase SIRT1-mediated HIF1α and elevating VEGFA. Bioengineered 2021. [PMID: 34696659 DOI: 10.1080/21655979.2021.1993718] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
10 Wang J, Zha J, Wang X. Knockdown of lncRNA NUTM2A-AS1 inhibits lung adenocarcinoma cell viability by regulating the miR-590-5p/METTL3 axis. Oncol Lett 2021;22:798. [PMID: 34630705 DOI: 10.3892/ol.2021.13059] [Reference Citation Analysis]
11 Aggarwal V, Tuli HS, Varol M, Tuorkey M, Sak K, Parashar NC, Barwal TS, Sharma U, Iqubal A, Parashar G, Jain A. NOTCH signaling: Journey of an evolutionarily conserved pathway in driving tumor progression and its modulation as a therapeutic target. Crit Rev Oncol Hematol 2021;164:103403. [PMID: 34214610 DOI: 10.1016/j.critrevonc.2021.103403] [Reference Citation Analysis]
12 Li M, Wang Q, Zhang X, Yan N, Li X. CircPUM1 promotes cell growth and glycolysis in NSCLC via up-regulating METTL3 expression through miR-590-5p. Cell Cycle 2021;20:1279-94. [PMID: 34097560 DOI: 10.1080/15384101.2021.1934625] [Reference Citation Analysis]
13 Qiu Z, Wang L, Liu H. Hsa_circ_0001982 promotes the progression of breast cancer through miR-1287-5p/MUC19 axis under hypoxia. World J Surg Oncol 2021;19:161. [PMID: 34082777 DOI: 10.1186/s12957-021-02273-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Zhu X, Kudo M, Huang X, Sui H, Tian H, Croce CM, Cui R. Frontiers of MicroRNA Signature in Non-small Cell Lung Cancer. Front Cell Dev Biol 2021;9:643942. [PMID: 33898432 DOI: 10.3389/fcell.2021.643942] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Ma YS, Shi BW, Lu HM, Xie PF, Xin R, Wu ZJ, Shi Y, Yin YZ, Hou LK, Jia CY, Wu W, Lv ZW, Yu F, Wang GR, Liu JB, Jiang GX, Fu D. MicroRNA-499 serves as a sensitizer for lung cancer cells to radiotherapy by inhibition of CK2α-mediated phosphorylation of p65. Mol Ther Oncolytics 2021;21:171-82. [PMID: 33997273 DOI: 10.1016/j.omto.2021.03.016] [Reference Citation Analysis]
16 Khandelwal A, Sharma U, Barwal TS, Seam RK, Gupta M, Rana MK, Vasquez KM, Jain A. Circulating miR-320a Acts as a Tumor Suppressor and Prognostic Factor in Non-small Cell Lung Cancer. Front Oncol 2021;11:645475. [PMID: 33833996 DOI: 10.3389/fonc.2021.645475] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
17 Gayosso-Gómez LV, Ortiz-Quintero B. Circulating MicroRNAs in Blood and Other Body Fluids as Biomarkers for Diagnosis, Prognosis, and Therapy Response in Lung Cancer. Diagnostics (Basel) 2021;11:421. [PMID: 33801442 DOI: 10.3390/diagnostics11030421] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Cui F, Luo P, Bai Y, Meng J. Silencing of Long Non-Coding RNA FGD5-AS1 Inhibits the Progression of Non-Small Cell Lung Cancer by Regulating the miR-493-5p/DDX5 Axis. Technol Cancer Res Treat 2021;20:1533033821990007. [PMID: 33550957 DOI: 10.1177/1533033821990007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Guo K, Qi D, Huang B. LncRNA MEG8 promotes NSCLC progression by modulating the miR-15a-5p-miR-15b-5p/PSAT1 axis. Cancer Cell Int 2021;21:84. [PMID: 33526036 DOI: 10.1186/s12935-021-01772-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Sharma U, Barwal TS, Khandelwal A, Malhotra A, Rana MK, Singh Rana AP, Imyanitov EN, Vasquez KM, Jain A. LncRNA ZFAS1 inhibits triple-negative breast cancer by targeting STAT3. Biochimie 2021;182:99-107. [PMID: 33429003 DOI: 10.1016/j.biochi.2020.12.026] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
21 Chen GQ, Liao ZM, Liu J, Li F, Huang D, Zhou YD. LncRNA FTX Promotes Colorectal Cancer Cells Migration and Invasion by miRNA-590-5p/RBPJ Axis. Biochem Genet 2021;59:560-73. [PMID: 33389283 DOI: 10.1007/s10528-020-10017-8] [Reference Citation Analysis]
22 Tuli HS, Mittal S, Aggarwal D, Parashar G, Parashar NC, Upadhyay SK, Barwal TS, Jain A, Kaur G, Savla R, Sak K, Kumar M, Varol M, Iqubal A, Sharma AK. Path of Silibinin from diet to medicine: A dietary polyphenolic flavonoid having potential anti-cancer therapeutic significance. Semin Cancer Biol 2021;73:196-218. [PMID: 33130037 DOI: 10.1016/j.semcancer.2020.09.014] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
23 Wang L, Zhao L, Wang Y. Circular RNA circ_0020123 promotes non-small cell lung cancer progression by sponging miR-590-5p to regulate THBS2. Cancer Cell Int 2020;20:387. [PMID: 32831647 DOI: 10.1186/s12935-020-01444-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
24 Xing L, Hong X, Chang L, Ren P, Zhang H. miR-365b regulates the development of non-small cell lung cancer via GALNT4. Exp Ther Med 2020;20:1637-43. [PMID: 32765677 DOI: 10.3892/etm.2020.8857] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
25 Ozawa PMM, Jucoski TS, Vieira E, Carvalho TM, Malheiros D, Ribeiro EMSF. Liquid biopsy for breast cancer using extracellular vesicles and cell-free microRNAs as biomarkers. Transl Res 2020;223:40-60. [PMID: 32413499 DOI: 10.1016/j.trsl.2020.04.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
26 Khandelwal A, Seam RK, Gupta M, Rana MK, Prakash H, Vasquez KM, Jain A. Circulating microRNA-590-5p functions as a liquid biopsy marker in non-small cell lung cancer. Cancer Sci 2020;111:826-39. [PMID: 31520555 DOI: 10.1111/cas.14199] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
27 Liu J, Li Y, Xue L, Fan M, Nie C, Wang Y, Zhang H, Qian H, Wang L. Circulating miR-27a-3p as a candidate for a biomarker of whole grain diets for lipid metabolism. Food Funct 2020;11:8852-65. [DOI: 10.1039/d0fo00830c] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]